Facilitated By

San Antonio Medical Foundation

News

  • This Could Be A Watershed Year For Infinity Pharma Stock

    ... and "nabpaclitaxel" products of Arcus Bioscience for front-line triple negative breast cancer. A slide from the San Antonio Breast Cancer Symposium ...

  • USDA official makes quick transition back to Sumner farm

    ... programs; trace animal diseases; and update biotech regulations for plants and farm animals as advances related to genetic traits are made.

  • Form 20-F ONCOLYTICS BIOTECH INC For: Dec 31

    The Board of Directors of Oncolytics Biotech Inc. (the “Corporation”) has adopted ... AWARE-1), 2020 San Antonio Breast Cancer Symposium (SABCS).

  • In-Depth Report on Biotechnology Reagents Market 2021|by Top Key players – Life Technologies ...

    Global Biotechnology Reagents Market Status and Forecast (2021-2027) by Region, Product Type & End-Use. The Lexis ... 1604 W San Antonio,.

  • Oncolytics Biotech Inc. (ONCY) CEO Dr. Matt Coffey on Q4 2020 Results - Earnings Call Transcript

    Data presented at the San Antonio Breast Cancer Symposium also showed that 72% of evaluable patients saw an increase in CelTIL, the study's primary ...